Indo Rama Synthetics (India) Limited (NSE:INDORAMA)
India · Delayed Price · Currency is INR 36.40
-1.16 (-3.09%)
Feb 19, 2026, 3:29 PM IST
NSE:INDORAMA Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 49,069 | 42,589 | 38,733 | 40,849 | 40,381 | 20,429 |
Revenue | 49,069 | 42,589 | 38,733 | 40,849 | 40,381 | 20,429 |
Revenue Growth (YoY) | 23.77% | 9.96% | -5.18% | 1.16% | 97.67% | -3.07% |
Cost of Revenue | 38,638 | 33,798 | 32,285 | 32,501 | 29,914 | 14,590 |
Gross Profit | 10,431 | 8,792 | 6,448 | 8,348 | 10,467 | 5,839 |
Selling, General & Admin | 1,401 | 1,359 | 1,457 | 1,336 | 1,197 | 991.7 |
Other Operating Expenses | 5,961 | 5,666 | 5,369 | 6,563 | 6,252 | 3,935 |
Operating Expenses | 7,844 | 7,505 | 7,217 | 8,212 | 7,762 | 5,264 |
Operating Income | 2,587 | 1,287 | -769 | 136 | 2,705 | 574.5 |
Interest Expense | -1,252 | -1,422 | -1,157 | -466.4 | -465.5 | -579.7 |
Interest & Investment Income | 5.6 | 5.6 | 6.6 | 112.5 | 32.6 | 20.5 |
Currency Exchange Gain (Loss) | -171.6 | -11.6 | -20.9 | -37.3 | 23.3 | 8 |
Other Non Operating Income (Expenses) | 18.2 | -55.9 | -69.7 | -86.7 | -115.1 | -36 |
EBT Excluding Unusual Items | 1,187 | -197.1 | -2,010 | -341.9 | 2,180 | -12.7 |
Gain (Loss) on Sale of Investments | - | - | - | -0.5 | 0.4 | 0.1 |
Gain (Loss) on Sale of Assets | -10.4 | -10.4 | -25.5 | -22.7 | 0.1 | -1.9 |
Asset Writedown | - | - | - | - | -1.7 | -116.3 |
Other Unusual Items | 194.5 | 221.5 | 1.1 | 117.9 | 15.8 | 164.7 |
Pretax Income | 1,372 | 14 | -2,034 | -247.2 | 2,194 | 33.9 |
Income Tax Expense | - | - | - | -1.6 | -496.2 | -1,100 |
Earnings From Continuing Operations | 1,372 | 14 | -2,034 | -245.6 | 2,691 | 1,134 |
Net Income | 1,372 | 14 | -2,034 | -245.6 | 2,691 | 1,134 |
Net Income to Common | 1,372 | 14 | -2,034 | -245.6 | 2,691 | 1,134 |
Net Income Growth | - | - | - | - | 137.31% | - |
Shares Outstanding (Basic) | 261 | 261 | 261 | 261 | 261 | 261 |
Shares Outstanding (Diluted) | 261 | 261 | 261 | 261 | 261 | 261 |
Shares Change (YoY) | -0.24% | - | - | - | - | 0.17% |
EPS (Basic) | 5.26 | 0.05 | -7.79 | -0.94 | 10.30 | 4.34 |
EPS (Diluted) | 5.26 | 0.05 | -7.79 | -0.94 | 10.30 | 4.34 |
EPS Growth | - | - | - | - | 137.31% | - |
Free Cash Flow | - | 3,524 | -3,568 | -4,463 | 1,200 | 1,562 |
Free Cash Flow Per Share | - | 13.49 | -13.67 | -17.09 | 4.60 | 5.98 |
Gross Margin | 21.26% | 20.64% | 16.65% | 20.44% | 25.92% | 28.58% |
Operating Margin | 5.27% | 3.02% | -1.98% | 0.33% | 6.70% | 2.81% |
Profit Margin | 2.79% | 0.03% | -5.25% | -0.60% | 6.66% | 5.55% |
Free Cash Flow Margin | - | 8.27% | -9.21% | -10.93% | 2.97% | 7.65% |
EBITDA | 3,109 | 1,739 | -408.8 | 409.1 | 2,959 | 858.2 |
EBITDA Margin | 6.34% | 4.08% | -1.05% | 1.00% | 7.33% | 4.20% |
D&A For EBITDA | 521.73 | 452.5 | 360.2 | 273.1 | 254.1 | 283.7 |
EBIT | 2,587 | 1,287 | -769 | 136 | 2,705 | 574.5 |
EBIT Margin | 5.27% | 3.02% | -1.98% | 0.33% | 6.70% | 2.81% |
Revenue as Reported | 49,433 | 42,880 | 38,801 | 41,093 | 40,444 | 20,637 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.